Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Cancers|June 2, 2021
The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical TrialRosa Ayala, Inmaculada Rapado, Esther Onecha, et al.
Blood Advances|October 14, 2022
Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemiaCatia Simoes, Maria-Carmen Chillon, David Martínez-Cuadrón, et al.
American Journal of Hematology|June 30, 2026
Quizartinib in Combination With FLAG-IDA for Relapsed or Refractory Acute Myeloid Leukemia (FLAG-QUIDA): A PETHEMA Phase I-II TrialTeresa Bernal, Javier Zambrano Márquez, Rebeca Rodríguez-Veiga, et al.
Cancer|February 24, 2021
A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemiaSusana Vives, David Martínez-Cuadrón, Juan Bergua Burgues, et al.
Annals of Hematology|December 19, 2023
Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experienceMarta Sobas, Wanda Knopinska-Posluszny, Beata Piątkowska-Jakubas, et al.
Leukemia Research|June 17, 2021
Adverse prognostic impact of complex karyotype (≥3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL)Eulàlia Genescà, Mireia Morgades, Celia González-Gil, et al.
Cancer|June 19, 2024
Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA RegistryJorge Labrador, David Martínez-Cuadrón, Blanca Boluda, et al.
Leukemia|October 20, 2020
Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing?David Martínez-Cuadrón, Josefina Serrano, Cristina Gil, et al.
Blood Advances|November 18, 2021
Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry studyDavid Martínez-Cuadrón, Juan E Megías-Vericat, Josefina Serrano, et al.
Hematological Oncology|January 9, 2026
CEBPA-bZIP Mutations in AML Patients Treated With Non-Intensive Therapy: A Study by the Spanish PETHEMA RegistryEsther Prados de la Torre, Josefina Serrano, Eva Barragán, et al.
Pageof 9